Click on image to view larger version.

Figure 2 1-Year Incidence and Relative Risk of the Primary End Point of Death, Myocardial Infarction, and Target Lesion Revascularization in Pre-Specified Subgroups

Relative risks associated with the use of paclitaxel-eluting stents (PES) as compared with sirolimus-eluting stents (SES) are shown with their 95% confidence intervals (CIs).